TY - JOUR
T1 - Neutrophil extracellular trap formation in anti-neutrophil cytoplasmic antibody-associated and large-vessel vasculitis
AU - Michailidou, Despina
AU - Kuley, Runa
AU - Wang, Ting
AU - Hermanson, Payton
AU - Grayson, Peter C.
AU - Cuthbertson, David
AU - Khalidi, Nader A.
AU - Koening, Curry L.
AU - Langford, Carol A.
AU - McAlear, Carol A.
AU - Moreland, Larry W.
AU - Pagnoux, Christian
AU - Seo, Philip
AU - Specks, Ulrich
AU - Sreih, Antoine G.
AU - Warrington, Kenneth J.
AU - Monach, Paul A.
AU - Merkel, Peter A.
AU - Lood, Christian
N1 - Publisher Copyright:
© 2023 Elsevier Inc.
PY - 2023/4
Y1 - 2023/4
N2 - Levels of neutrophil extracellular traps (NETs) were measured in plasma of healthy controls (HC, n = 30) and patients with granulomatosis with polyangiitis (GPA, n = 123), microscopic polyangiitis (MPA, n = 61), Takayasu's arteritis (TAK, n = 58), and giant cell arteritis (GCA, n = 68), at times of remission or activity and correlated with levels of the platelet-derived thrombospondin-1 (TSP-1). Levels of NETs were elevated during active disease in patients with GPA (p < 0.0001), MPA (p = 0.0038), TAK (p < 0.0001), and GCA (p < 0.0001), and in remission for GPA, p < 0.0001, MPA, p = 0.005, TAK, p = 0.03, and GCA, p = 0.0009. All cohorts demonstrated impaired NET degradation. Patients with GPA (p = 0.0045) and MPA (p = 0.005) had anti-NET IgG antibodies. Patients with TAK had anti-histone antibodies (p < 0.01), correlating with presence of NETs. Levels of TSP-1 were increased in all patients with vasculitis, and associated with NET formation. NET formation is a common process in vasculitides. Targeting NET formation or degradation could be potential therapeutic approaches for vasculitides.
AB - Levels of neutrophil extracellular traps (NETs) were measured in plasma of healthy controls (HC, n = 30) and patients with granulomatosis with polyangiitis (GPA, n = 123), microscopic polyangiitis (MPA, n = 61), Takayasu's arteritis (TAK, n = 58), and giant cell arteritis (GCA, n = 68), at times of remission or activity and correlated with levels of the platelet-derived thrombospondin-1 (TSP-1). Levels of NETs were elevated during active disease in patients with GPA (p < 0.0001), MPA (p = 0.0038), TAK (p < 0.0001), and GCA (p < 0.0001), and in remission for GPA, p < 0.0001, MPA, p = 0.005, TAK, p = 0.03, and GCA, p = 0.0009. All cohorts demonstrated impaired NET degradation. Patients with GPA (p = 0.0045) and MPA (p = 0.005) had anti-NET IgG antibodies. Patients with TAK had anti-histone antibodies (p < 0.01), correlating with presence of NETs. Levels of TSP-1 were increased in all patients with vasculitis, and associated with NET formation. NET formation is a common process in vasculitides. Targeting NET formation or degradation could be potential therapeutic approaches for vasculitides.
KW - Anti-neutrophil cytoplasmic antibody associated vasculitis
KW - Histone
KW - Large vessel vasculitis
KW - Neutrophil extracellular traps
KW - Neutrophils
KW - Platelet activation
KW - Thrombospondin-1
UR - http://www.scopus.com/inward/record.url?scp=85150926332&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85150926332&partnerID=8YFLogxK
U2 - 10.1016/j.clim.2023.109274
DO - 10.1016/j.clim.2023.109274
M3 - Article
C2 - 36878421
AN - SCOPUS:85150926332
SN - 1521-6616
VL - 249
JO - Clinical Immunology
JF - Clinical Immunology
M1 - 109274
ER -